Latest Breaking News On - ஹால்பெரின் வெற்ணிலி - Page 1 : vimarsana.com

What Happened The psychedelic medicine biotech company noted that the study will examine the effects of various “doses of mescaline and the role of the serotonin 5-HT2A receptor in mescaline-induced altered state of consciousness.” Mescaline is a classic serotonergic hallucinogen similar to LSD psilocybin, famous for its long, non-regulated history of spiritual use. The research is scheduled to begin in May at the University Hospital Basel Liechti Lab in Basel, Switzerland. Why It Matters MindMed said that the importance of this study lies in the fact that valid studies on the effects of different doses of mescaline, including placebo, are few and far between. The company will also gather data from the trial and create a foundation for future clinical trials on the medical potential of mescaline.

Matthias liechtiHalperin wernliUniversity hospital basel liechti labஹால்பெரின் வெற்ணிலி